Medullary thyroid carcinoma – case reports
MUDr. Andrea Jurečková
Klinika komplexní onkologické péče, Masarykův onkologický ústav, Brno
Two case reports of patients with metastatic medullary thyroid carcinoma treated with tyrosine kinase inhibitors as a 1st line treatment are presented. The effectiveness of the treatment is compared - long-term treatment response in patient with early detected metastatic disease versus quick progression in patient with late diagnosis of advanced carcinoma and large proportion of metastatic lesions.
medullary thyroid carcinoma, targeted therapy, vandetanib, cabozantinib
The full article is only available to subscribers
Become a regular subscriber to our Oncological Review...